You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 7, July 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Endocrine Disease of Head & Neck
 •Endocrine Diseases
 •Thyroid/ Parathyroid Diseases
 •Alert me on articles by topic

Patterns of Lateral Neck Metastasis in Papillary Thyroid Carcinoma

Michael E. Kupferman, MD; Michael Patterson, BS; Susan J. Mandel, MD, MPH; Virginia LiVolsi, MD; Randal S. Weber, MD

Arch Otolaryngol Head Neck Surg. 2004;130:857-860.

Background  Although lymphatic metastasis does not affect overall survival for patients with differentiated thyroid carcinoma, locoregional control can be improved with cervical lymphadenectomy. The major morbidity of neck dissection (ND) for the management of regional metastases is spinal accessory (cranial nerve XI) dysfunction. To avoid this complication, some surgeons have advocated a limited ND.

Objective  To establish the patterns of lateral cervical metastases in differentiated thyroid carcinoma and the role of comprehensive ND, we performed a review of our experience with comprehensive ND.

Study Design  Retrospective chart review.

Patients and Methods  Between 1997 and 2002, a total of 39 consecutive patients (31 women and 8 men) underwent 44 NDs for the management of lateral cervical metastases. Preoperative cytologic analysis revealed papillary carcinoma in all 39 patients (100%). All specimens were labeled and mapped by the operating surgeon to identify each level. The incidence of positive disease was determined in relation to the extent of lymphadenectomy for all dissected levels.

Results  All patients underwent ND at levels II through V; 7 (17%) of the 44 ND specimens included level I nodes. The incidence of metastatic disease in level II nodes was 52% (23/44 specimens). Similarly, 25 specimens (57%) contained histologic metastases at level III. Metastatic disease was noted in 18 level IV nodes (41%) and 9 level V nodes (21%). One (14%) of the 7 specimens with level I nodes contained tumor.

Conclusions  Cervical metastases from papillary thyroid carcinoma occur in predictable patterns, with disease commonly present at levels II through V. We believe that a comprehensive ND, including removal of transverse cervical and spinal accessory nodes, is necessary for the complete clearance of lateral metastases.


From the Department of Otolaryngology–Head and Neck Surgery (Drs Kupferman and Weber and Mr Patterson), the Department of Medicine, Division of Endocrinology (Dr Mandel), and the Department of Pathology and Laboratory Medicine (Dr LiVolsi), University of Pennsylvania School of Medicine, Philadelphia. Dr Weber is now with the Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston. The authors have no relevant financial interest in this article.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lateral Cervical Lymph Node Metastases from Papillary Thyroid Carcinoma: Pattern of Nodal Metastases and Optimal Strategy for Neck Dissection
Roh et al.
Ann. Surg. Oncol. 2008;15:1177-1182.
ABSTRACT | FULL TEXT  

Impact of Preoperative Ultrasonographic Staging of the Neck in Papillary Thyroid Carcinoma
Gonzalez et al.
Arch Otolaryngol Head Neck Surg 2007;133:1258-1262.
ABSTRACT | FULL TEXT  

Level IIb Lymph Node Metastasis in Neck Dissection for Papillary Thyroid Carcinoma
Lee et al.
Arch Otolaryngol Head Neck Surg 2007;133:1028-1030.
ABSTRACT | FULL TEXT  

High Prevalence and Possible de Novo Formation of BRAF Mutation in Metastasized Papillary Thyroid Cancer in Lymph Nodes
Vasko et al.
J. Clin. Endocrinol. Metab. 2005;90:5265-5269.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.